- Home
- NVO vs APP Comparison
NVO vs APP Comparison
Compare NVO & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- APP
- Stock Information
- Founded
- NVO 1923
- APP 2012
- Country
- NVO Denmark
- APP United States
- Employees
- NVO N/A
- APP N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- APP EDP Services
- Sector
- NVO Health Care
- APP Technology
- Exchange
- NVO Nasdaq
- APP Nasdaq
- Market Cap
- NVO 243.4B
- APP 203.1B
- IPO Year
- NVO N/A
- APP 2021
- Fundamental
- Price
- NVO $48.46
- APP $617.05
- Analyst Decision
- NVO Buy
- APP Buy
- Analyst Count
- NVO 10
- APP 21
- Target Price
- NVO $80.40
- APP $604.60
- AVG Volume (30 Days)
- NVO 13.5M
- APP 4.2M
- Earning Date
- NVO 11-05-2025
- APP 11-05-2025
- Dividend Yield
- NVO 2.54%
- APP N/A
- EPS Growth
- NVO 10.06
- APP 148.74
- EPS
- NVO 3.67
- APP 8.23
- Revenue
- NVO $49,580,393,058.00
- APP $6,307,450,000.00
- Revenue This Year
- NVO $9.21
- APP $20.00
- Revenue Next Year
- NVO $5.64
- APP $33.60
- P/E Ratio
- NVO $13.22
- APP $74.97
- Revenue Growth
- NVO 16.64
- APP 78.13
- 52 Week Low
- NVO $45.05
- APP $160.52
- 52 Week High
- NVO $112.52
- APP $745.61
- Technical
- Relative Strength Index (RSI)
- NVO 26.48
- APP 51.80
- Support Level
- NVO $48.49
- APP $617.20
- Resistance Level
- NVO $49.90
- APP $652.87
- Average True Range (ATR)
- NVO 1.21
- APP 26.16
- MACD
- NVO -0.58
- APP 0.04
- Stochastic Oscillator
- NVO 22.84
- APP 66.12
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.